Insider · CIK 0001503738

Cavan John T

Reports to the SEC for 2 companies · BRIDGEWATER, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001503738

Forms 4 and 5

Insider transactions

13 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-05-18	HEPAHepion Pharmaceuticals, Inc. · Stock OptionsA Award	Chief Financial Officer	AAward	+1.2M sh	—	—	1,581,060
2021-02-18	HEPAHepion Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+10K sh	$2.00	+$20K	14,800
2020-11-25	HEPAHepion Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+4,500 sh	$1.62	+$7,290	4,800
2020-08-19	HEPAHepion Pharmaceuticals, Inc. · Stock OptionsA Award	Chief Financial Officer	AAward	+160K sh	—	—	381,060
2020-04-03	HEPAHepion Pharmaceuticals, Inc. · Stock OptionsA Award	Chief Financial Officer	AAward	+215K sh	—	—	221,059
2019-07-24	HEPAHepion Pharmaceuticals, Inc. · Stock OptionsA Award	Chief Financial Officer	AAward	+5,820 sh	—	—	6,059
2018-07-03	HEPAHepion Pharmaceuticals, Inc. · Series C Convertible Preferred StockP Purchase	Chief Financial Officer	PPurchase	+15 sh	$1000.00	+$15K	15
2018-07-03	HEPAHepion Pharmaceuticals, Inc. · WarrantsP Purchase	Chief Financial Officer	PPurchase	+8,625 sh	$1000.00	+$8.63M	8,625
2018-01-03	HEPAHepion Pharmaceuticals, Inc.A Award	Chief Financial Officer	AAward	+101K sh	—	—	167,947
2017-07-20	HEPAHepion Pharmaceuticals, Inc. · Stock OptionsA Award	Chief Financial Officer	AAward	+15K sh	—	—	133,688
2017-07-06	HEPAHepion Pharmaceuticals, Inc.A Award	Chief Financial Officer	AAward	+46.7K sh	—	—	66,726
2017-06-20	HEPAHepion Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+20K sh	$0.65	+$13K	20,000
2016-08-26	HEPAHepion Pharmaceuticals, Inc. · Stock OptionsA Award	Chief Financial Officer	AAward	+18.7K sh	—	—	118,688

Recent filings

Accepted (ET)
May 204
Cavan John T0001104659-21-069938
SEC(opens sec.gov)
Feb 184
Cavan John T0001104659-21-025196
SEC(opens sec.gov)
Nov 304
Cavan John T0001104659-20-130531
SEC(opens sec.gov)
Aug 214
Cavan John T0001104659-20-097591
SEC(opens sec.gov)
Apr 74
Cavan John T0001104659-20-044168
SEC(opens sec.gov)
Jul 254
Cavan John T0001104659-19-041851
SEC(opens sec.gov)
Jul 34
Cavan John T0001104659-18-043797
SEC(opens sec.gov)
Jan 54
Cavan John T0001104659-18-000925
SEC(opens sec.gov)
Jul 214
Cavan John T0001104659-17-046277
SEC(opens sec.gov)
Jul 74
ContraVir Pharmaceuticals, Inc.0001104659-17-044101
SEC(opens sec.gov)
Jun 224
ContraVir Pharmaceuticals, Inc.0001104659-17-040822
SEC(opens sec.gov)
Aug 294
ContraVir Pharmaceuticals, Inc.0001104659-16-141912
SEC(opens sec.gov)

Companies

Address

C/O AEGERION PHARMACEUTICALS, INC. CENTERPOINTE IV, 1140 ROUTE 22 EAST

BRIDGEWATER, NJ, 08807